Position in AMGN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$7,061,702
+$246,016 QoQ
Shares Held
19,501
+0.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.07%
of 13F equity value
Holder Rank
#676
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argyle Capital Management, LLC holds $43,679,401 across 8 Drug Manufacturers - General names. AMGN ranks #3 (16.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,767 | $12,914,263 | |
| 2 | MRK |
Merck & Co., Inc.
|
62,540 | $8,036,390 | |
| 3 | AMGN |
Amgen Inc
This page
|
19,501 | $7,061,702 | |
| 4 | JNJ |
Johnson & Johnson
|
25,649 | $6,514,076 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
72,282 | $4,164,888 | |
| 6 | PFE |
Pfizer Inc
|
155,636 | $3,747,714 | |
| 7 | ABBV |
AbbVie Inc.
|
3,450 | $868,158 | |
| 8 | NVS |
Novartis AG
|
2,375 | $372,210 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,061,702 | 19,501 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $6,815,686 | 19,371 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $6,340,322 | 19,371 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $5,466,496 | 19,371 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $5,408,576 | 19,371 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $6,097,345 | 19,571 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $5,052,767 | 19,386 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $6,122,312 | 19,001 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $6,177,448 | 19,771 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $6,198,460 | 21,801 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $6,500,899 | 22,571 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $6,919,494 | 25,746 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $5,549,611 | 24,996 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $6,395,738 | 26,456 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $6,935,271 | 26,406 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $6,007,811 | 26,654 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $6,484,918 | 26,654 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $6,445,470 | 26,654 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $6,176,326 | 27,454 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $5,944,418 | 27,954 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $6,850,350 | 28,104 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $6,942,794 | 27,904 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $6,415,687 | 27,904 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $7,153,079 | 28,144 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $6,685,215 | 28,344 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $5,806,998 | 28,644 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||